Cholera Vaccine Market

Cholera Vaccine Market contains market size and forecasts of Cholera Vaccine (Oral Route) in global, including the following market information:

• Global Cholera Vaccine (Oral Route) Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Cholera Vaccine (Oral Route) Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Cholera Vaccine (Oral Route) companies in 2021 (%)

The global Cholera Vaccine (Oral Route) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Shanchol Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Cholera Vaccine (Oral Route) include PaxVax, Sanofi, Valneva and EuBiologics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Cholera Vaccine (Oral Route) manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Cholera Vaccine (Oral Route) Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Cholera Vaccine (Oral Route) Market Segment Percentages, by Type, 2021 (%)

• Shanchol
• Dukoral
• Vaxchora
• Others

Global Cholera Vaccine (Oral Route) Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Cholera Vaccine (Oral Route) Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Research & Academic Laboratories
• Pharmaceutical & Biotechnology Companies
• Others

Global Cholera Vaccine (Oral Route) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Cholera Vaccine (Oral Route) Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Cholera Vaccine (Oral Route) revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Cholera Vaccine (Oral Route) revenues share in global market, 2021 (%)
• Key companies Cholera Vaccine (Oral Route) sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Cholera Vaccine (Oral Route) sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• PaxVax
• Sanofi
• Valneva
• EuBiologics